202 related articles for article (PubMed ID: 9781656)
1. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.
Ullmann R; Schwendel A; Klemen H; Wolf G; Petersen I; Popper HH
Hum Pathol; 1998 Oct; 29(10):1145-9. PubMed ID: 9781656
[TBL] [Abstract][Full Text] [Related]
2. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.
Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H
Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
[TBL] [Abstract][Full Text] [Related]
5. The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues.
Ullmann R; Petzmann S; Klemen H; Fraire AE; Hasleton P; Popper HH
Genes Chromosomes Cancer; 2002 May; 34(1):78-85. PubMed ID: 11921285
[TBL] [Abstract][Full Text] [Related]
6. [CGH findings in neuroendocrine tumours of the lung].
Johnen G; Krismann M; Jaworska M; Müller KM
Pathologe; 2003 Jul; 24(4):303-7. PubMed ID: 14513278
[TBL] [Abstract][Full Text] [Related]
7. Genetic changes in the spectrum of neuroendocrine lung tumors.
Onuki N; Wistuba II; Travis WD; Virmani AK; Yashima K; Brambilla E; Hasleton P; Gazdar AF
Cancer; 1999 Feb; 85(3):600-7. PubMed ID: 10091733
[TBL] [Abstract][Full Text] [Related]
8. Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study.
Petzmann S; Ullmann R; Halbwedl I; Popper HH
Virchows Arch; 2004 Aug; 445(2):151-9. PubMed ID: 15235910
[TBL] [Abstract][Full Text] [Related]
9. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations.
Welborn J; Jenks H; Taplett J; Walling P
Cancer Genet Cytogenet; 2004 Nov; 155(1):33-41. PubMed ID: 15527900
[TBL] [Abstract][Full Text] [Related]
10. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
[TBL] [Abstract][Full Text] [Related]
11. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors.
Kovatich A; Friedland DM; Druck T; Hadaczek P; Huebner K; Comis RL; Hauck W; McCue PA
Cancer; 1998 Sep; 83(6):1109-17. PubMed ID: 9740075
[TBL] [Abstract][Full Text] [Related]
12. MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma.
Lei L; Jiang Z; Zhang G; Cheng Q; Lu H
World J Surg Oncol; 2018 Jun; 16(1):110. PubMed ID: 29914531
[TBL] [Abstract][Full Text] [Related]
13. MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma.
Debelenko LV; Swalwell JI; Kelley MJ; Brambilla E; Manickam P; Baibakov G; Agarwal SK; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Travis WD; Emmert-Buck MR
Genes Chromosomes Cancer; 2000 May; 28(1):58-65. PubMed ID: 10738303
[TBL] [Abstract][Full Text] [Related]
14. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
Travis WD
Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
[TBL] [Abstract][Full Text] [Related]
15. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
16. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
[TBL] [Abstract][Full Text] [Related]
17. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors.
Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F
Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
19. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
[TBL] [Abstract][Full Text] [Related]
20. Bronchopulmonary neuroendocrine tumors.
Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]